From Infections in Medical field.
FDA Approves Single-Dose Zithromax
Pfizer, Inc, says it has been granted FDA favorable grab for the use of Zithromax (azithromycin) as both a single-dose and 3-day regimen for pediatric otitis media.
Previously, Zithromax was indicated as a 5-day regimen.
This is a part of article CDC Adds Vaccine to Disease Aid Options. Taken from "Azithromycin Zithromax" Information Blog
No comments:
Post a Comment